HAMILTON, Canada

Quang Huy To

This inventor holds 3 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Canopy Growth Corporation. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Quang Huy To. Retrieved from https://idiyas.com/inventor/quang-huy-to

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Quang Huy To: Innovator in Cannabinoid Derivatives

Introduction

Quang Huy To is a notable inventor based in Hamilton, Canada. He has made significant contributions to the field of cannabinoid research, holding 3 patents that focus on cannabinoid derivatives and their potential applications in medicine.

Latest Patents

His latest patents include innovative compounds that serve as cannabinoid receptor ligands. The first patent discloses a compound of formula (I), which can be used in the treatment or prevention of diseases associated with various cannabinoid receptors, such as CB1, CB2, and others. The second patent relates to cannabinoid derivatives of Formula (I), specifically those with a carboxamide group, which are potential inhibitors of cannabinoid receptors, including CB1 and CB2.

Career Highlights

Quang Huy To is currently associated with Canopy Growth Corporation, a leading company in the cannabis industry. His work focuses on developing pharmaceutical compositions that leverage cannabinoid derivatives for therapeutic purposes.

Collaborations

He collaborates with notable colleagues such as Jeffrey Alan Omeara and Siawash Ahmar, contributing to advancements in cannabinoid research.

Conclusion

Quang Huy To's innovative work in cannabinoid derivatives positions him as a key figure in the field, with promising implications for medical treatments. His contributions continue to shape the landscape of cannabinoid research and its applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…